For most men with low-risk prostate cancer, the recommended strategy is active surveillance with regular testing to check for cancer growth rather than immediate treatment, according to guidelines from the American Society ...
Feb 18, 2016
0
2
Cancer screening has never been shown to "save lives" as advocates claim, argue experts in The BMJ today.
Jan 7, 2016
0
198
(HealthDay)—Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age ...
Dec 29, 2015
1
2
For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned because it leads to ...
Dec 10, 2015
0
1
(HealthDay)—Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy (MRF-TB) improves detection and risk stratification of high-grade disease and limits detection of clinically insignificant prostate cancer, ...
Nov 17, 2015
0
12
Travellers exposed to antibiotic-resistant bacteria may force a change to common medical procedures that rely on effective antibiotics, say researchers from The University of Queensland.
Sep 30, 2015
0
47
A new urine-based test improved prostate cancer detection - including detecting more aggressive forms of prostate cancer - compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
May 18, 2015
0
42
(HealthDay)—Among a group of men with an initial negative prostate biopsy, clinically significant cancer is still found in subsequent repeat sampling rounds, according to a study published in the April issue of The Journal ...
Apr 13, 2015
0
4
Monitoring prostate cancer (PC) by active surveillance (AS), with the expectation to initiate treatment if the cancer progresses, is a preferred initial option for men with low-risk PC and a life expectancy of at least 10 ...
Feb 19, 2015
0
35
Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study published ...
Jan 27, 2015
1
13
